Table 3.
| ||||||||
---|---|---|---|---|---|---|---|---|
compnd | R3 = | R4 = | cLogP |
Ki (nM) TR-FRETa |
Cell Proliferation Assays GI50 (nM)a |
Selectivityb |
||
WDR5 | MV4:11 | MOLM-13 | K562 | K562/MV4:11 | ||||
| ||||||||
25 | Me | 1.8 | 0.23 ± 0.03 | 1500 ± 160 | 3100 ± 200 | >30000 | >20 | |
26 | Me | 2.3 | 0.039 ± 0.005 | 170 ± 53 | 330 ± 120 | 13000 ± 2500 | 76 | |
27 | Me | 2.3 | 0.020 ± 0.004 | 23 ± 9.1 | 33 ± 12 | 3600 ± 310 | 160 | |
28 | Me | 2.3 | 0.59 ± 0.19 | 3000 ± 840 | 4700 ± 790 | 22000 ± 6500 | 7 | |
29 | Me | 2.3 | 0.064 ± 0.009 | 270 ± 94 | 550 ± 200 | 13000 ± 7100 | 48 | |
30 | Me | 1.7 | <0.02 | 24 ± 8.6 | 39 ± 14 | 9500 ± 4800 | 400 | |
31 | Me | 2.8 | <0.02 | 16 ± 7.3 | 25 ± 9.6 | 4100 ± 1300 | 260 | |
32 | Et | 2.3 | <0.02 | 34 ± 18 | 59 ± 30 | 13000 ± 10000 | 380 | |
33 | Et | 3.4 | <0.02 | 24 ± 8.2 | 43 ± 15 | 5600 ± 1100 | 230 |
TR-FRET Ki and cell proliferation GI50 values represent four independent replicate determinations ± standard deviation.
Selectivity is defined as GI50,K562/GI50,MV4:11 and is used to generally distinguish between on- and off-target inhibition mechanisms.